| Company/Division name | Rentschler Biopharma |
| Parent company | Rentschler Biopharma |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 70 |
| Year reshoring announced: | 2019 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Milford |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Eco-system synergies, Proximity to customers/market, Under-utilized capacity |
